ABBOTT PARK, Ill., May 16, 2023 /PRNewswire/ -- Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of ...
Abbott has touted the potential of its neuromodulation portfolio in reducing patient and healthcare burdens associated with chronic pain following the positive results of three five-year analyses. The ...
In an episode of ABC’s Four Corners this week, the use of spinal cord stimulators for chronic back pain was brought into question. Spinal cord stimulators are devices implanted surgically which ...
Abbott ABT recently announced the first usage of its Eterna spinal cord stimulator (SCS) system in Canada. This marks a significant milestone in the company’s approach to chronic pain management. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results